Esempio: Heart Attack

Studi clinici sponsorizzati da Pevion Biotech Ltd

Totale 4 risultati

NCT01067131

Completato

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Condizioni: Recurrent Vulvovaginal Candidiasis
NCT00445419

Completato

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Condizioni: Chronic Hepatitis C
NCT00513669

Completato

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

Condizioni: Falciparum Malaria
NCT00408668

Completato

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

Condizioni: Malaria; Malaria, Falciparum